Link
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations
Organization: United States Centers for Disease Control (CDC)Published: 2023
The 2023 Southern Hemisphere seasonal influenza vaccine reduced the risk for influenza-associated hospitalizations by 52%. Circulating influenza viruses were genetically similar to those targeted by the 2023–24 Northern Hemisphere influenza vaccine formulation. This vaccine might offer similar protection if these viruses predominate during the coming Northern Hemisphere influenza season.
Resource Group:
Evidence
Product Type: Report
Communicable Diseases
Influenza
Monitoring and Surveillance
Vaccine Preventable Disease Surveillance
Global Surveillance
Product Type: Report
Category:
Vaccine Preventable Diseases,Communicable Diseases,Influenza,Monitoring and Surveillance,Vaccine Preventable Disease Surveillance,Global Surveillance Vaccine Preventable DiseasesCommunicable Diseases
Influenza
Monitoring and Surveillance
Vaccine Preventable Disease Surveillance
Global Surveillance
Region:
International
Language:
English
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.